Australia markets closed

Takeda Pharmaceutical Company Limited (TAK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
17.25+0.20 (+1.17%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close17.05
Open17.08
Bid17.13 x 3200
Ask17.25 x 3200
Day's range17.06 - 17.25
52-week range15.30 - 20.00
Volume1,928,250
Avg. volume4,113,183
Market cap54.066B
Beta (5Y monthly)1.17
PE ratio (TTM)32.86
EPS (TTM)0.52
Earnings dateN/A
Forward dividend & yield0.85 (4.93%)
Ex-dividend date29 Sep 2020
1y target est23.01
  • Why Molecular Templates Stock Crashed Today
    Motley Fool

    Why Molecular Templates Stock Crashed Today

    Shares of Molecular Templates (NASDAQ: MTEM) closed down 23.6% on Monday. The big drop came after the company announced that it was resuming full rights of engineered toxin bodies (ETB) candidate TAK-169 from Takeda (NYSE: TAK). Molecular Templates also said that it's discontinuing the development of MT-3724, another experimental ETB.

  • Takeda Hosts Wave 1 Pipeline Market Call
    Business Wire

    Takeda Hosts Wave 1 Pipeline Market Call

    Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) ("Takeda") today announced that it will host a conference call on April 6, 2021 to provide updates on select New Molecular Entities (NMEs) in its Wave 1 pipeline portfolio. With several NME regulatory filings expected by year-end FY2021, the company will outline plans for organic and sustainable revenue growth over the next several years.

  • Business Wire

    Takeda Completes Sale of Select OTC and Non-Core Assets to Orifarm

    Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) ("Takeda") today announced the completion of its previously-announced sale of a portfolio of select products to Orifarm Group ("Orifarm") for a total value of up to $670 million USD. The portfolio includes approximately 130 over-the-counter (OTC) and prescription pharmaceutical products sold in Europe, and two manufacturing sites located in Denmark and Poland. This divestment agreement was first announced in April 2020.